How May LUCENTIS Help People With wAMD?

LUCENTIS may help maintain* vision for people with wet AMD

*Maintained is defined as losing less than 15 letters or 3 lines on the eye chart after 1 year.

In a study of 459 people with wet AMD after 1 year of treatment:

LUCENTIS MONTHLY


91% of 230 people maintained* vision

NO LUCENTIS


60% of 229 people maintained* vision

In another study of 280 people with wet AMD after 1 year of treatment:

LUCENTIS MONTHLY


98% of 139 people maintained* vision

NO LUCENTIS


66% of 141 people maintained* vision


LUCENTIS may also help people with wet AMD see more letters on an eye chart.

In a study of 459 people with wet AMD after 1 year of treatment:
Study results from a study of 459 people with wet AMD after 1 year of treatment
In another study of 280 people with wet AMD after 1 year of treatment:
Study results from a study of 280 people with wet AMD after 1 year of treatment

Patient Support

LUCENTIS Patient Support Program

Enroll in the LUCENTIS Patient Support Program for resources like live one-on-one phone support, emails, or brochures.

Financial Assistance Options

Financial Assistance Options

There may be options to help you afford LUCENTIS, no matter what type of health insurance you have. Learn about Genentech Access Solutions.

Who is LUCENTIS for? LUCENTIS® is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD).

What important safety information should I know about LUCENTIS? You should not use LUCENTIS if you have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. LUCENTIS is not for everyone. Some LUCENTIS patients have had detached retinas and serious eye infections. If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away.

Some patients have had increased eye pressure before and within 1 hour of an injection. Your eye doctor should check your eye pressure and eye health before and after your LUCENTIS injection. 

Uncommonly, LUCENTIS patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes. 

Some LUCENTIS patients have serious side effects related to the injection. These include serious infections inside the eye, detached retinas, and cataracts. The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, anemia, nausea and cough. 

LUCENTIS is for prescription use only.

You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.

For additional Safety Information, please talk to your doctor and see the LUCENTIS full Prescribing Information.